N-3 Polyunsaturated Fatty Acids Modulate In-Vitro T Cell Function in Type I Diabetic Patients-Reference-Cited by-同舟云学术

N-3 Polyunsaturated Fatty Acids Modulate In-Vitro T Cell Function in Type I Diabetic Patients

Published:2008-04-08 Issue:6 Volume:43 Page:485-497
ISSN:0024-4201
Container-title:Lipids
language:en
Short-container-title:Lipids

Author:

Merzouk Sid Ahmed,Saker Meriem,Reguig Karima Briksi,Soulimane Nassima,Merzouk Hafida,Guermouche Baya,Berrouiguet Abdelsslam Yahia,Hichami Aziz,Narce Michel,Khan Naim Akhtar

Publisher

Wiley

Subject

Cell Biology,Organic Chemistry,Biochemistry

Reference47 articles.

1. Itoh M (1989) Immunological aspects of diabetes mellitus: prospects for pharmacological modification. Pharmacol Ther 44:351–406

2. Shah BR, Hux JE (2003) Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26:510–513

3. Balasubramanyam M, Premanand C, Mohan V (2002) The lymphocyte as a cellular model to study insights into the pathophysiology of diabetes and its complications. Ann NY Acad Sci 958:399–402

4. Otton R, Mendonca JR, Curi R (2002) Diabetes causes marked changes in lymphocyte metabolism. J Endocrinol 174:55–61

5. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14:29–34

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis;European Journal of Nutrition;2024-08-06

2. The protective effect of docosahexaenoic acid on mitochondria in a SH-SY5Y model of rotenone-induced toxicity;2024-07-16

3. Effects of subcutaneous vs. oral nanoparticle-mediated insulin delivery on hemostasis disorders in type 1 diabetes: A rat model study;Heliyon;2024-05

4. Molecular effects of Vitamin-D and PUFAs metabolism in skeletal muscle combating Type-II diabetes mellitus;Gene;2024-04

5. Eicosapentaenoic acid induces an anti-inflammatory transcriptomic landscape in T cells implicating a pathway independent of triglyceride lowering in cardiovascular risk reduction;2024-03-17